Healthcare -
Biotechnology - NASDAQ - US
$ 7.47
1.41 %
$ 160 M
Market Cap
-1.59
P/E
ENTA - NET INCOME
Net Income ENTA - Enanta Pharmaceuticals, Inc.
-116 M
LAST VALUE
2.37%
2 YEAR CAGR
-28.49%
5 YEAR CAGR
-15.89%
10 YEAR CAGR